Written by: Aaron Katsman | July 15, 2008
With shares in financials and hi-tech getting crushed, I think we are about to see a new trend develop. You’re probably thinking that I will suggest something along the lines of re-branding. Nope. While we did that, I am talking about a change much less cosmetic and much more fundamental. Taking publicly traded companies private. Today’s NY Post (no new revelations on A-Rod/Madonna so I decided to look at the business section) has an interesting report on struggling investment bank Lehman Brothers (LEH) trying to figure out a way to go private.
“According to sources, talks internally centering on privatizing Lehman have gotten very serious consideration after a blistering onslaught of rumors and questions about the firm’s solvency have caused the venerable bond shop to shed more than 79 percent this year.”
Lehman isn’t alone. Israeli hi-tech firm BluePhoenix (BPHX), whose shares have been nailed as well, has mentioned that they are thinking about going private as well.
For companies this is a great situation. They can go private, reset the cap-tables, retain employees- who are currently holding options that even a deep sea diver would have trouble recovering- by issuing new options. Then they can focus on stabilizing their business, getting back to profitability, and then in a few years after this current crisis is a memory, go public in a ‘much anticipated’ IPO. Ultimately, the companies will be back trading at pre-bear market levels. Senior management, who share much if not all the blame for the current debacle, will come out smelling like roses, as their stock will be worth hundreds of millions of dollars.
Sounds good. So who loses? You guessed it. The same people who always get left holding the bag. The INVESTORS. You see, they are the ones who bought into Lehman at $75 a share 12 months ago, and will be lucky to get $15 on a deal of some sort. They heard analysts beat the drum on BluePhoenix at $22 about 9 months ago, and decided to invest, only to cringe every time they hit refresh on Yahoo finance to see if the stock has held the $4 level.
Going private may be a great solution for a company to weather the current market malaise and return to health. Unfortunately for investors, it will be another in a long line of recognized tax losses.
Aaron Katsman, IsraelNewsletter.com
Disclosure: Author’s fund has a position in BPHX. He has no position in any other stock mentioned as of 7/15/08.
Please see our Disclaimer HERE.
NEW! Introducing Israel Opportunity Investor, our monthly subscription-only newsletter. Stay ahead of the game and make smart decisions in Israel stocks. Go here to learn more.
Aaron Katsman is Managing Editor of the Israel Opportunity Investor newsletter. He is lead portfolio manager for the Israel Growth Portfolio and Managing Director of America Israel Investment Associates, LLC. For more information, go to www.israelnewsletter.com or call 1-888-327-6179, or email aaron@profile-financial.com.
Leave a comment
Category:
IPO,
Uncategorized,
banking,
bphx,
editor's pick
Tags:
A-Rod,
bank stocks,
Bear market,
bluephoenix,
deep sea diver,
investing trands,
investment bank,
IPO,
Israeli IPO's,
Lehman Brothers,
Madonna,
taking public companies private
Written by: Aaron Katsman | April 28, 2008
The entire interview with Gemini’s Carmel Sofer is part of our new subscription newsletter, Israel Opportunity Investor. You can find out more about the product and the opportunities we cover at www.israelnewsletter.com.
Can you tell us a bit about Gemini?
Carmel Sofer, Partner: Gemini was one of Israel’s first VCs and is 15 years old. We now manage more than $600 million via 4 funds. We’ve just closed our 4th fund and are in the process of raising our 5th fund, which we’re targeting to be $200 million. We’ve had over 30 exits including Saifun and recently, Traiana. (Continue »)
Comments (1)
Category:
CMVT.PK,
Comverse,
IPO,
Uncategorized,
VC,
cmvt,
communications,
dox,
interviews,
investing,
investor insight,
israel,
israel ingenuity,
mobile communications,
startup,
telecommunications
Tags:
Akamai,
amdocs,
Carmel Sofer,
Comverse,
Gemini Funds,
google,
internet,
Israeli hi-tech,
Israeli Ingenuity,
Massive Impact,
mobile,
Modu,
Msystems,
Primesense,
shopping.com
Written by: Zack Miller | February 7, 2008
Someone called us recently to ask about a newish ETF called the SPDR Emerging Middle East & Africa (Amex: GAF). The ETF
is heavily weighted around three countries — South Africa (65%), Israel (17%) and Egypt (6%).
There are other ETFs that include exposure to Israel but as far as we know, this ETF currently has the largest exposure.
Israel as a destination
We like Israel (but hey, we’re biased). While Israel is not putting up double-digit GDP growth like China, we are seeing close to 4-5%.
Not too shabby.
Foreign capital is flowing
We’re continuing to see money coming into Israel looking for a home. Canaan Partners just announced another fund that will be targeting opportunities in Israel.
Can Israel do better?
And if you ask Netanyahu [subscription required], we could see close to 8%, if certain pro-market policies are put into place. Even Netanyahu’s detractors credit his cuts in welfare benefits, the removal of remaining currency and capital controls, and liberalization of the banking sector as cutting the way for an amazing economic recovery.
Check out Eze Vidra’s post, “Israel 2008: What the Bulls and the Bears are saying“, for some good forecasts of what various analysts are looking for from the Israeli economy in 2008.
What does the ETF hold?
Check out the GAF’s holdings. What you’ll see is that Israel’s 11% weighting is driven by the fact that Teva Pharmaceuticals (Nasdaq: TEVA) is the ETF’s largest holding at over a whopping 9%. We then see Israel Chemical (2%), Bank Leumi (1.43%) and Bank Hapoalim (1.41%). Elbit Systems (Nasdaq: ESLT) is also in there (1.06%). The rest of the Israel holdings each account for less than 1% of the SPDR Emerging Middle East & Africa Fund.
Investors in Israel from abroad may like the fact that this fund holds locally traded companies that aren’t dually listed or carry a corresponding ADR in the US.
So, what’s an investor interested in Israel to do?
That said, 17% of a fund that has exposure to really different economies may not be enough for foreign investors looking to trade locally-traded Israeli shares. Also, TEVA’s weighting at 9% of the overall fund means that Teva alone accounts for over 50% of the total Israeli exposure.
Teva may be a great company but it’s not indicative of the Israeli market as a whole. I’d like to see more exposure to Israel Chemicals, the Israeli banks, Bezeq, 012.Smile (Nasdaq: SMLC), the Mobile phone carries including Partner (Nasdaq: PTNR) and Cellcom (NYSE: CEL), let alone all the newer, smaller, tech firms listed locally.
What about mobile fixed telecom players like Alvarion (Nasdaq: ALVR) and Ceragon (Nasdaq: CRNT)? Both have taken a worse beating than Britney has received from the paparazzi.
I’d like to see a country ETF also include local retailers like Blue Square-Israel (NYSE: BSI)
Israel investors may be better off weighting for new offerings in the works as we hear that Barclays and another firm has an Israel ETF in registration.
Please see our Disclaimer HERE.
NEW! Introducing Israel Opportunity Investor, our monthly subscription-only newsletter. Stay ahead of the game and make smart decisions in Israel stocks. Go here to learn more.
Comments (6)
Category:
Bank of Israel,
IPO,
VC,
economy,
in the news,
investing,
israel
Tags:
alvarion,
alvr,
Bank of Israel,
CEL;partner; cellphone; Israel,
ceragon,
israel ingenuity,
israel newsletter,
israel opportunity investor,
israel stocks,
israel stocks in the US,
israeli economy,
israeli stocks; Ehud Olmert,
Teva,
VC
Written by: Zack Miller | October 28, 2007
Zack Miller
IsraelNewsletter.com
It’s great when you read about your own service provider going public. It’s a tremendous feeling of accomplishment as a consumer when you think your well-spent dollars have helped propel your ISP into the big leagues. So I read with excitement today that my ISP, 012 Smile.Communications (SMLC) is gearing up for an IPO this week.
SeekingAlpha has a short write up on the IPO. I love Smile’s service — I love their logo (cure little smiley a la Incredimail (MAIL)). At first blush, I don’t love the IPO. 40% yoy revenue growth off the back of a 60% rise in cost of revenues. Not a particularly jiggy biz in my mind.
In fact, it hearkens to the same discussion we’ve raised before at IsraelNewsletter.com about the interest in investing in native Israeli service providers: where’s the growth? Read Aaron “Buy Everything” Katsman’s write up on Israeli cellular leader: Cellcom (CEL). Aaron’s pretty tough on CEL and explains that growth is going to eventually have to come from international expansion. The same will probably hold true for SMLC.
I’m reserving my smile for now on 012 Smile.Communication’s IPO. Let’s watch how the market receives the new offering.
Disclosure: Author’s fund has no position in any stock mentioned as of 10/28/2007.
Please see our Disclaimer HERE.
Like what you see? Sign up to receive daily updates from IsraelNewsletter here.
*******************************
Zack Miller is the lead equity analyst for America Israel Investment Associates, LLC. and a former equity analyst for a leading multinational hedge fund. For more information, go to www.israelnewsletter.com or call 1-888-327-6179, or email zack@profile-financial.com